November 17th, 2026US loses measles elimination status; CDC outlines re-elimination planThe US lost measles elimination status after 26 years; CDC and partners plan to regain it via MMR vaccination and $100M in health department funding.Read more
November 16th, 2026Roflumilast cream 0.05% eases itch, improves QOL in infants with ADCaregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.Read more
November 12th, 2026Risankizumab shows 52-week efficacy in pediatric psoriasis trialFull OptIMMize-1 results show high skin clearance rates with risankizumab in children and teens with psoriasis, sustained through 52 weeks.Read more
November 10th, 2026Exploring AhR agonists in pediatric atopic dermatitisEmily Becker, MD, discusses the role of AhR agonists, skin barrier function, and steroid-free treatment options for pediatric atopic dermatitis.Read more
November 10th, 2026Pediatric CP-CRE incidence nearly doubled, driven by NDM, CDC findsCDC data show pediatric CP-CRE incidence rose 92% from 2019 to 2024, driven by NDM-CRE, mostly in children with complex medical needs.Read more
November 10th, 2026How pediatricians can reframe vaccine conversationsJulie Sweetland, PhD, shares strategies to improve vaccine conversations by explaining the science, acknowledging parental concerns, and building trust.Read more
November 9th, 2026Air pollution tied to higher pediatric atopic dermatitis burdenA meta-analysis of 52 studies links NO2, SO2, and particulate matter to more pediatric atopic dermatitis visits and higher prevalence.Read more
November 6th, 2026Maternal RSVpreF 78% effective against infant RSV hospitalizationA meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.Read more